Diamonds and Dogs
Oil keeps cooking. Dow component, Chevron (CVX) is up 5% not far from a 52 week high after easily beating earnings estimates even as sales declined 12.2% year over year to $30.14 billion. The trend is in their favor as third quarter results reflect an improvement from the first two quarters of this year. Looking forward, December production is expected to be between 2.65-2.70 million barrels per day up 5% from current levels.
Healthcare can't get out of its own way. Plenty of dogs in the healthcare space as Amgen (AMGN) drops 10% while McKeeson (MCK) drops 24% on earnings. McKeeson, one of the largest US prescription drug wholesalers slashed its fiscal year earnings forecast to an range of $12.35 to $12.85 per share, from its prior outlook of $13.43 to $13.93 per share due to drug pricing pressures. The CEO for McKeeson said in his conference call that competitors had significantly undercut their pricing, so they were compelled to respond. Looks like a race to the bottom.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.